Pharmacokinetics and bioavailability of indapamide — A new antihypertensive drug

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00548396PMID 7106164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Semiautomated assay for indapamide in biological fluids.

  1981cited by this paper
• Pharmacokinetics of indapamide in dogs.

  1981cited by this paper
• Evaluation of Indapamide in the Treatment of Hypertension

  1979cited by this paper
• Fluorometric assay for urinary indapamide.

  1978cited by this paper
• Pharmacokinetics and metabolism of indapamide: A review

  1977influential reference
• Indapamide : measurement by a fluorescence assay

  1977cited by this paper
• A physiological approach to hepatic drug clearance

  1975cited by this paper
• Commentary: a physiological approach to hepatic drug clearance.

  1975cited by this paper
• Fundamentals of Clinical Pharmacokinetics

  1975cited by this paper
• Multivariate Statistical Methods

  1968cited by this paper

• Preparation of Three-Dimensional Graphene Oxide Electric-Field/Temperature-Sensitive Hydrogels and Transdermal-Controlled Release Drug Delivery Study

  2023cites this paper
• Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide.

  2022cites this paper
• In vitro–in vivo correlations for three different commercial immediate-release indapamide tablets

  2014cites this paper
• Chiral liquid chromatography resolution and stereoselective pharmacokinetic study of indapamide enantiomers in rats.

  2013cites this paper
• Diuretics

  2012cites this paper
• Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein

  2007cites this paper
• A sensitive LC-ESI-MS method for the determination of indapamide in human plasma: method and clinical applications.

  2006cites this paper
• Influence of Indapamide and Chlorthalidone on Reperfusion‐Induced Ventricular Fibrillation in Isolated Guinea Pig Hearts

  1995cites this paper
• Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension.

  1995cites this paper
• Block of IKs, the slow component of the delayed rectifier K+ current, by the diuretic agent indapamide in guinea pig myocytes.

  1994cites this paper
• High-performance liquid chromatographic method for the determination of indapamide in human whole blood.

  1993cites this paper
• Clinical Pharmacokinetics of Some Newer Diuretics

  1987cites this paper
• A Review of 10 Years of Experience with Indapamide as an Antihypertensive Agent

  1985cites this paper
• Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.

  1984cites this paper
• Lack of effect of bilateral nephrectomy on the pharmacokinetics of 14C-indapamide (REV 2555) and its metabolites in the dog.

  1984cites this paper
• Pharmacokinetics and clinical pharmacology of indapamide.

  1983cites this paper
• The Disposition of 14C‐indapamide in Man

  1983cites this paper
• Multi-centre clinical investigation of indapamide in the United States: a review.

  1983cites this paper
• Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment.

  1983cites this paper
• Preclinical studies of indapamide, a new 2-methylindoline antihypertensive diuretic.

  1983cites this paper